SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABT: Abbott Laboratories
ABT 124.51-1.7%3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HerbVic who wrote (9)5/15/2002 1:22:04 PM
From: HerbVic   of 33
 
Gene Tests: Medicine's New Gold Mine
Matthew Herper, Forbes.com 12.14.01, 8:00 AM ET

NEW YORK - Only a few years ago, Abbott Laboratories and Roche Holding were racing neck and neck for the lead spot in the medical diagnostics business. Then, in November 1999, the Food and Drug Administration (FDA) convinced a federal judge to close down one of Abbott's plants, derailing Abbott's diagnostics strategy. Meanwhile, Roche decided that genetic tests could be the key to its future.
forbes.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext